Page last updated: 2024-11-03

probenecid and Hyperparathyroidism

probenecid has been researched along with Hyperparathyroidism in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Hyperparathyroidism: A condition of abnormally elevated output of PARATHYROID HORMONE (or PTH) triggering responses that increase blood CALCIUM. It is characterized by HYPERCALCEMIA and BONE RESORPTION, eventually leading to bone diseases. PRIMARY HYPERPARATHYROIDISM is caused by parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. SECONDARY HYPERPARATHYROIDISM is increased PTH secretion in response to HYPOCALCEMIA, usually caused by chronic KIDNEY DISEASES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCOTT, JT1
DIXON, AS1
BYWATERS, EG1
Hisatome, I1
Ishimura, M1
Sasaki, N1
Yamakawa, M1
Kosaka, H1
Tanaka, Y1
Kouchi, T1
Mitani, Y1
Yoshida, A1
Kotake, H1

Other Studies

2 other studies available for probenecid and Hyperparathyroidism

ArticleYear
ASSOCIATION OF HYPERURICAEMIA AND GOUT WITH HYPERPARATHYROIDISM.
    British medical journal, 1964, Apr-25, Volume: 1, Issue:5390

    Topics: Adenoma; Blood Chemical Analysis; Diagnosis; Gout; Humans; Hyperparathyroidism; Hyperuricemia; Nephr

1964
Renal handling of urate in two patients with hyperuricemia and primary hyperparathyroidism.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:6

    Topics: Aged; Female; Humans; Hyperparathyroidism; Kidney; Kidney Tubules; Male; Probenecid; Pyrazinamide; U

1992